BMP-2 production in vitro: BMP-2 production was detected from all samples of RBMCs transduced with Lenti-MLV-BMP-2 and Lenti-CMV-BMP -2. Although the BMP -2 production did decrease over time, transduced cells continued to show transgene expression of BMP -2 six weeks after transduction (Fig 1) . Cells transduced with Lenti-MLV-BMP-2 at MOI=25 were highest at all time points. Bone formation in vivo: Radiographic examination revealed ectopic bone formation in mice implanted with lentivirus-BMP-2 transduced RBMCs. Implantation of Lenti -MLV-BMP -2 transduced cells particularly induced strong bone formation (Fig 2) . Histology revealed bony trabeculae a nd mature osseous components, including cortical bone, within the muscle pouch at three weeks after implantation of transduced cells (Fig 3) .
DISCUSSION
These results demonstrated that lentiviral vectors were able to infect RBMCs with a high tranduction efficiency and induce long term in vitro transgene expression of BMP-2. The most promising results were observed with Lenti-MLV-BMP -2 at an MOI of 25. Transduced cells produced biologically active BMP-2 that induced ectopic bone formation in vivo. To our knowledge this is the first demonstration of enhancement of bone repair with a lentiviral vector. Lentivirus-BMP -2 has the potential to induce long term expression of BMP-2 at the site of bone defects. This may be advantageous when developing tissue engineering strategies to repair large bone defects. We are optimistic that these vectors will demonstrate even longer transgene expression as original cultures Lenti -EGFP transduced cells continue to show strong GFP production at 20 weeks. The safety of these lentiviral vectors requires further study before they can be adapted to treat non-lethal conditions in humans. Poster No: 0324
